KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Working Capital Changes (2016 - 2026)

Ionis Pharmaceuticals has reported Other Working Capital Changes over the past 14 years, most recently at $7.4 million for Q1 2026.

  • For Q1 2026, Other Working Capital Changes rose 153.87% year-over-year to $7.4 million; the TTM value through Mar 2026 reached -$48.6 million, down 182.47%, while the annual FY2025 figure was -$69.7 million, 369.68% down from the prior year.
  • Other Working Capital Changes for Q1 2026 was $7.4 million at Ionis Pharmaceuticals, up from -$19.1 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $56.2 million in Q2 2024 and troughed at -$61.8 million in Q4 2023.
  • A 5-year average of $277529.4 and a median of -$1.2 million in 2024 define the central range for Other Working Capital Changes.
  • Biggest five-year swings in Other Working Capital Changes: skyrocketed 5806.74% in 2023 and later plummeted 1214.27% in 2025.
  • Year by year, Other Working Capital Changes stood at $26.2 million in 2022, then plummeted by 335.39% to -$61.8 million in 2023, then skyrocketed by 128.65% to $17.7 million in 2024, then crashed by 208.07% to -$19.1 million in 2025, then skyrocketed by 138.63% to $7.4 million in 2026.
  • Business Quant data shows Other Working Capital Changes for IONS at $7.4 million in Q1 2026, -$19.1 million in Q4 2025, and -$16.1 million in Q3 2025.